Get started
Author

Nicolas M. Furiak

Observed names: N Furiak, N. Furiak, NM Furiak, Nicolas Furiak, Nicolas M Furiak, Н. Фуриак
OpenAlex ID: A5013533143
Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia
2009 · Haya Ascher-Svanum, Baojin Zhu, et al. · BMC Research Notes · 61
PDF
Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model
2011 · Nicolas M. Furiak, Haya Ascher-Svanum, et al. · Current Medical Research and Opinion · 49
Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States
2009 · Nicolas M Furiak, Haya Ascher-Svanum, et al. · Cost Effectiveness and Resource Allocation · 45
PDF
Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States
2012 · Haya Ascher-Svanum, Nicolas M. Furiak, et al. · Journal of Medical Economics · 36
PDF
Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model
2010 · Nicolas M Furiak, Robert W Klein, et al. · BMC Medical Informatics and Decision Making · 15
PDF
Development, Validation, and Application of a Microsimulation Model to Predict Stroke and Mortality in Medically Managed Asymptomatic Patients with Significant Carotid Artery Stenosis
2007 · Harry J. Smolen, David J. Cohen, et al. · Value in Health · 13
Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model
2012 · Nicolas M Furiak, James C Gahn, et al. · Annals of General Psychiatry · 7
PDF
Screening and treatment for Alzheimer's disease: Predicting population‐level outcomes
2012 · Nicolas M. Furiak, Kristin Kahle‐Wrobleski, et al. · Alzheimer s & Dementia · 5
Economic considerations of cognition and functional outcomes in patients with schizophrenia: A systematic literature review
2014 · Nicolas Furiak, Amy Duhig, et al. · Schizophrenia Research Cognition · 3
PDF
Pmh21 Cost-effectiveness of Olanzapine Long-acting Injection in the Treatment of Non-adherence Patients With Schizophrenia in the United States
2009 · H Ascher-Svanum, NM Furiak, et al. · Value in Health · 2
PDF
Use of a decision tree model to estimate the economic benefits of reducing schizophrenia illness relapse
2013 · N. Furiak, R.W. Klein, et al. · Value in Health · 1
Экономическая Эффективность Нескольких Атипичных Антипсихотиков В Виде Таблеток Для Рассасывания По Сравнению Со Стандартной Пероральной Терапией При Лечении Шизофрении В Сша
2012 · Х. Ашер-Сванум, Н. Фуриак, et al. · Современная терапия психических расстройств
PDF
PDB18 Validation of a Diabetes Modeling Framework
2012 · N. Furiak, M. Bansal, et al. · Value in Health
Pdb74 Beta-verification of a Diabetes Modeling Framework Against Published Cohort Trials
2011 · N. Furiak, M. Bansal, et al. · Value in Health
PDF
Pnd22 Quantifying Cost Outcomes Differentiated by Gender and Age in the Treatment of Migraine Headache Using Step and Stratified Care
2011 · N. Furiak, M. Bansal · Value in Health
Pdb33 Evaluation of Cost and Clinical Outcomes by Hba1c at Diagnosis Using Various Diabetes Treatment Strategies
2010 · LJ Lee, RW Klein, et al. · Value in Health
Pnd6 Modeling the Estimated Cost-savings of Stratified Care for Migraine Headaches From a U.s. Perspective
2010 · N Furiak, M Bansal · Value in Health
PDF
Pmc30 Using an Encounter-based Database to Validate a Disease Progression Model: Lessons for Modelers
2009 · TM Klein, RC Wielage, et al. · Value in Health
PDF
Cost-effectiveness of Orally Dissolving Olanzapine Tablets in the Treatment of Schizophrenia in the Usa
2008 · Haya Ascher-Svanum, Robert Klein, et al. · Schizophrenia Research
Cost-effectiveness of Generic Risperidone Versus Olanzapine and Other Antipsychotics in Standard Formulations in Patients With Schizophrenia in the Usa
2008 · Robert Klein, Haya Ascher-Svanum, et al. · Schizophrenia Research
Pmh35 Cost-effectiveness of Orally Dissolving Olanzapine Tablets in the Treatment of Schizophrenia in the Usa
2008 · H Ascher-Svanum, NM Furiak, et al. · Value in Health
Pmh23 Cost-effectiveness of Olanzapine Versus Generic Risperidone and Other Antipsychotics in Standard Oral Formulations in Patients With Schizophrenia in the Us
2007 · H Ascher-Svanum, NM Furiak, et al. · Value in Health
PDF
Pmh38 Adherence Levels and Differential Use of Mental Health Services in the Treatment of Schizophrenia
2006 · NA Thomas, B Zhu, et al. · Value in Health
PDF
An analysis of luminosity classification of red stars using 2MASS photometric data to create an unbiased sample of red dwarf stars
2002 · Nicolas M. Furiak · Cardinal Scholar (Ball State University)
Intermediate-Band Photometric Luminosity Descrimination for M Stars
1995 · T. H. Robertson, Nicolas M. Furiak · AAS
Works count: 25
Citation count: 237
H-index: 7
I10-index: 6
Year
Topic
Type